Cecilia Vindrola-Padros1, Karen E Dyer2, John Cyrus3, Irene Machowa Lubker3. 1. Department of Applied Health Research, University College London, London, United Kingdom. 2. Department of Health Behavior and Policy, Virginia Commonwealth University, Richmond, VA, United States. 3. Tompkins-McCaw Library, Virginia Commonwealth University Libraries, Richmond, VA, United States.
Abstract
OBJECTIVE: In spite of efforts to guarantee patients are adequately informed about their risk of fertility loss and offered treatment for fertility preservation (FP), previous studies have reported that this topic is not routinely discussed with patients, especially with younger patient populations. A mixed method systematic review was undertaken to explore the factors shaping the discussion of FP with children (0-15 years) and adolescents/young adults (16-24 years) with cancer. METHODS: Six databases were searched independently using a combination of keywords and controlled vocabulary/subject headings relating to cancer and fertility. Inclusion criteria consisted of: (a) being published in a peer-reviewed journal, (b) a focus on healthcare professionals' (HCPs') beliefs, attitudes, or practices regarding fertility issues in cancer patients, (c) primary data collection from HCPs, and (d) a focus on HCPs who provide services to young patients. Of the 6276 articles identified in the search, 16 articles presenting the results of 14 studies were included in the final review. RESULTS: Common themes reported across studies indicate that five main factors influence HCPs' discussion of FP with young cancer patients: (a) HCPs' knowledge, (b) HCPs' sense of comfort, (c) patient factors (i.e., sexual maturity, prognosis, partnership status, and whether or not they initiate the conversation), (d) parent factors (i.e., HCPs' perception of the extent of their involvement), and (e) availability of educational materials. CONCLUSIONS: Future work should ensure that HCPs possess knowledge of cancer-related FP and that they receive adequate training on how to consent and discuss information with young patients and their parents.
OBJECTIVE: In spite of efforts to guarantee patients are adequately informed about their risk of fertility loss and offered treatment for fertility preservation (FP), previous studies have reported that this topic is not routinely discussed with patients, especially with younger patient populations. A mixed method systematic review was undertaken to explore the factors shaping the discussion of FP with children (0-15 years) and adolescents/young adults (16-24 years) with cancer. METHODS: Six databases were searched independently using a combination of keywords and controlled vocabulary/subject headings relating to cancer and fertility. Inclusion criteria consisted of: (a) being published in a peer-reviewed journal, (b) a focus on healthcare professionals' (HCPs') beliefs, attitudes, or practices regarding fertility issues in cancerpatients, (c) primary data collection from HCPs, and (d) a focus on HCPs who provide services to young patients. Of the 6276 articles identified in the search, 16 articles presenting the results of 14 studies were included in the final review. RESULTS: Common themes reported across studies indicate that five main factors influence HCPs' discussion of FP with young cancerpatients: (a) HCPs' knowledge, (b) HCPs' sense of comfort, (c) patient factors (i.e., sexual maturity, prognosis, partnership status, and whether or not they initiate the conversation), (d) parent factors (i.e., HCPs' perception of the extent of their involvement), and (e) availability of educational materials. CONCLUSIONS: Future work should ensure that HCPs possess knowledge of cancer-related FP and that they receive adequate training on how to consent and discuss information with young patients and their parents.
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: Richard A Anderson; Annette Weddell; Helen A Spoudeas; Carolyn Douglas; Stephen M Shalet; Gill Levitt; W Hamish B Wallace Journal: Hum Reprod Date: 2008-07-09 Impact factor: 6.918
Authors: B Elizabeth Oosterhuis; Tress Goodwin; Michaela Kiernan; Melissa M Hudson; Gary V Dahl Journal: Pediatr Blood Cancer Date: 2008-01 Impact factor: 3.167
Authors: Gwendolyn P Quinn; Susan T Vadaparampil; Clement K Gwede; Cheryl Miree; Lindsey M King; Heather B Clayton; Crystal Wilson; Pamela Munster Journal: J Cancer Surviv Date: 2007-06 Impact factor: 4.062
Authors: Caroline S Dorfman; Juliann M Stalls; Coleman Mills; Shannon Voelkel; Mallori Thompson; Kelly S Acharya; Karen C Baker; Lars M Wagner; Nolan Miller; Amy Boswell; Cheyenne Corbett Journal: J Oncol Navig Surviv Date: 2021-10
Authors: Leena Nahata; Antoinette Anazodo; Brooke Cherven; Shanna Logan; Lillian R Meacham; Cathy D Meade; Sara Zarnegar-Lumley; Gwendolyn P Quinn Journal: Pediatr Blood Cancer Date: 2020-07-06 Impact factor: 3.167
Authors: G M Armuand; J Nilsson; K A Rodriguez-Wallberg; J Malmros; J Arvidson; C Lampic; L Wettergren Journal: Psychooncology Date: 2017-08-25 Impact factor: 3.894
Authors: Andrea Covelli; Marcia Facey; Erin Kennedy; Christine Brezden-Masley; Abha A Gupta; Ellen Greenblatt; Nancy N Baxter Journal: JAMA Netw Open Date: 2019-11-01
Authors: Lauren Folgosa Cooley; James Wren; Mary Kate Keeter; Isaac Lam; Nelson Bennett; Robert E Brannigan Journal: BMC Urol Date: 2020-07-27 Impact factor: 2.264